Companies:

 

Articles:

 

Biotech & Pharma

Cover Image for Island Pharmaceuticals Expedites Purchase of Galidesivir RNA Anti-Viral Program

Island Pharmaceuticals Expedites Purchase of Galidesivir RNA Anti-Viral Program

Cover Image for Orthocell Posts Record Full-Year Revenue, Takes Remplir and Striate into New Global Markets

Orthocell Posts Record Full-Year Revenue, Takes Remplir and Striate into New Global Markets

Cover Image for Argent BioPharma to Supply Cannabinoid Treatment for Drug-Resistant Epilepsy in Slovenia

Argent BioPharma to Supply Cannabinoid Treatment for Drug-Resistant Epilepsy in Slovenia

Cover Image for EVE Health Group Submits First Commercial Order For Dyspro Dysmenorrhoea Treatment

EVE Health Group Submits First Commercial Order For Dyspro Dysmenorrhoea Treatment

Cover Image for Prescient Therapeutics’ PTX-100 Progresses to Phase 2a Trials after Outstanding Phase 1b Results

Prescient Therapeutics’ PTX-100 Progresses to Phase 2a Trials after Outstanding Phase 1b Results

Cover Image for Next Science Agrees to US$50m Asset Buyout by Italian Healthcare Firm Demetra

Next Science Agrees to US$50m Asset Buyout by Italian Healthcare Firm Demetra

Cover Image for Orthocell’s Remplir nerve repair technology sees first surgical use in US procedure

Orthocell’s Remplir nerve repair technology sees first surgical use in US procedure

Cover Image for Percheron Therapeutics acquires worldwide licence to commercialise HMBD-002 cancer therapy

Percheron Therapeutics acquires worldwide licence to commercialise HMBD-002 cancer therapy

Cover Image for Neurizon Therapeutics confirms potential of NUZ-001 as platform therapy for ALS and Huntington’s disease

Neurizon Therapeutics confirms potential of NUZ-001 as platform therapy for ALS and Huntington’s disease

Cover Image for BPH Global books $150,000 in first-month revenue from Indonesian seaweed venture

BPH Global books $150,000 in first-month revenue from Indonesian seaweed venture

Cover Image for Singular Health secures PNS deal and finalises $8m placement for US expansion

Singular Health secures PNS deal and finalises $8m placement for US expansion

Cover Image for Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial

Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial

Cover Image for INOVIQ reports 88% kill rate of breast and lung cancer cells in CAR-exosome therapy study

INOVIQ reports 88% kill rate of breast and lung cancer cells in CAR-exosome therapy study

Cover Image for Emyria’s Empax PTSD trauma care program gains funding support from Medibank Private

Emyria’s Empax PTSD trauma care program gains funding support from Medibank Private

Cover Image for Amplia Therapeutics reports first pathological complete response in ACCENT pancreatic cancer trial

Amplia Therapeutics reports first pathological complete response in ACCENT pancreatic cancer trial

Cover Image for EVE Health and TeleDocs to launch online prescription service for erectile dysfunction and period pain treatments

EVE Health and TeleDocs to launch online prescription service for erectile dysfunction and period pain treatments

Cover Image for Syntara advances myelofibrosis trial with Phase 2 data and SNT-5505 FDA fast track designation

Syntara advances myelofibrosis trial with Phase 2 data and SNT-5505 FDA fast track designation

Cover Image for EVE Health Group completes takeover of Nextract, strengthens executive team

EVE Health Group completes takeover of Nextract, strengthens executive team

Cover Image for Cyclopharm granted maximum US market patent extension for Technegas imaging kit

Cyclopharm granted maximum US market patent extension for Technegas imaging kit

Cover Image for EZZ Life Science signs $21m distribution deal for South-East Asia with ROFA Enterprises

EZZ Life Science signs $21m distribution deal for South-East Asia with ROFA Enterprises

Cover Image for Chimeric Therapeutics gains FDA fast-track approval for CHM CDH17 gastrointestinal cancer candidate

Chimeric Therapeutics gains FDA fast-track approval for CHM CDH17 gastrointestinal cancer candidate

Cover Image for EVE Health Group begins stability testing of oral treatments for ED and period pain

EVE Health Group begins stability testing of oral treatments for ED and period pain

Cover Image for Invion advances skin cancer treatment with positive safety data for INV043 in Phase I/II trial

Invion advances skin cancer treatment with positive safety data for INV043 in Phase I/II trial

Cover Image for Immutep delivers major breakthrough with 59.6% response rate in lung cancer trial

Immutep delivers major breakthrough with 59.6% response rate in lung cancer trial

Cover Image for Optiscan Imaging and Mayo Clinic to collaborate on robotic breast cancer surgery technology

Optiscan Imaging and Mayo Clinic to collaborate on robotic breast cancer surgery technology

Cover Image for Memphasys pilot study confirms RoXsta’s potential as high-throughput antioxidant diagnostic tool

Memphasys pilot study confirms RoXsta’s potential as high-throughput antioxidant diagnostic tool

Cover Image for Algorae Pharmaceuticals teams with Peter MacCallum Centre to validate AI-predicted cancer drug synergies

Algorae Pharmaceuticals teams with Peter MacCallum Centre to validate AI-predicted cancer drug synergies

Cover Image for Clinuvel Pharmaceuticals reaches patient recruitment milestone ahead of Phase III Scenesse vitiligo trial

Clinuvel Pharmaceuticals reaches patient recruitment milestone ahead of Phase III Scenesse vitiligo trial

Cover Image for Immutep delivers strong survival results in efti-Keytruda head and neck cancer immunotherapy trial

Immutep delivers strong survival results in efti-Keytruda head and neck cancer immunotherapy trial

Cover Image for Dimerix and Amicus Therapeutics partner to commercialise kidney disease treatment DMX-200 in the US

Dimerix and Amicus Therapeutics partner to commercialise kidney disease treatment DMX-200 in the US